Mechanistic & Functional In Vitro Profiling

This platform functions as the essential, data-driven filter that determines which drug candidates merit advancement into costly and time-consuming animal studies. It moves beyond simple screening to deliver a comprehensive molecular and functional profile of each compound.

What it delivers:

Quantitative Potency Metrics:Precise IC₅₀, EC₅₀, and KI values that define the concentration needed for biological effect.
Mechanistic Validation:Direct proof of target engagement and confirmation of the intended mechanism of action (MOA) at the molecular and pathway level.
Early Developability Assessment:Identification of potential red flags in ADME properties, chemical stability, and immunotoxicity long before in vivo testing.

Strategic Value for Your Pipeline:

De-risks Development:Filters out weak or problematic candidates early, saving significant resources on failed in vivo studies.
Optimizes Lead Selection:Provides a multi-parameter dataset to objectively choose the most promising lead series for progression.
Informs Study Design:Generates critical data on potency and exposure-response to design more efficient and predictive animal studies with optimal dosing.

In essence, this isn’t just testing, it’s strategic portfolio management. It ensures that only compounds with a strong scientific rationale and favorable in vitro profile move forward, dramatically increasing the probability of success in subsequent preclinical and clinical stages.

Send a Message

Request a Call Back

Cell Viability & Cytotoxicity Screening

This foundational analysis determines a drug candidate’s safety profile by establishing its toxic and therapeutic concentration windows. We measure cell viability and discriminate between apoptosis and necrosis to derive key potency metrics such as IC₅₀ and EC₅₀, establishing a preliminary therapeutic index. These insights are vital for early-stage screening, molecular optimization, and advancing the most promising leads into in vivo evaluation. Key Items:

MTT Assay:Assesses mitochondrial metabolic activity as a proxy for viable cell count and overall cellular fitness.
XTT/WST Assay:Offers enhanced aqueous solubility over MTT, ideal for automated, high-throughput screening formats.
Resazurin Assay:Detects viable cells via fluorometric/colorimetric signal from dye reduction, providing a sensitive viability readout.
LDH Release Assay:Quantifies extracellular LDH enzyme as a direct marker of cell membrane integrity loss and necrotic death.
Annexin V/PI Apoptosis Assay:Precisely identifies apoptotic cells by detecting externalized phosphatidylserine, with PI co-staining to distinguish late apoptosis from necrosis.

Learn more

Mechanistic & Molecular Pathway Assays

This module directly confirms and quantifies a drug’s molecular-level impact. Its purpose is to demonstrate that a drug candidate successfully modulates its intended target and triggers the expected downstream biological responses within relevant signaling pathways. These analyses validate the mechanism of action (MOA) and provide crucial insights for lead optimization. Key Items:

ELISA Panels:Quantitative and specific measurement of target proteins (e.g., phosphoproteins, cytokines) in cell lysates.
Western Blot:Analysis of the presence, size, and expression level of specific pathway proteins, with emphasis on post-translational modifications like phosphorylation.
qPCR (Real-Time PCR):Precise, quantitative assessment of changes in mRNA expression levels for target and pathway-related genes.
Multiplex Cytokine Profiling:Simultaneous profiling of dozens of cytokines and chemokines from a small sample to evaluate immune and inflammatory responses.
Reporter Gene Assays:Use of genetically engineered cells to directly measure the activity of a specific signaling pathway (e.g., NF-κB, AP-1) following treatment.

Learn more

Target Engagement & Binding Studies

This section verifies and quantifies the direct physical interaction between a drug and its intended biological target (e.g., receptor, enzyme, protein). The goal is to prove the fundamental principle that the drug actually binds to its target—the first and essential step for any subsequent pharmacological activity. These analyses define binding affinity, specificity, and interaction kinetics. Key Items:

Receptor-Binding Curves:Generation of binding isotherms to determine key parameters like KD (Dissociation Constant) and Bmax (Maximum Binding), indicating binding strength and capacity.
Receptor Occupancy Assays:Measurement of the percentage of receptors occupied by the drug at a given concentration, directly correlating with biological effect.
Flow Cytometry-Based Binding Confirmation:Confirmation of drug binding to targets on the surface of live cells, assessing specificity in a physiological context.
SPR (Surface Plasmon Resonance) Kinetics:Label-free, real-time measurement of interaction kinetics (association ka and dissociation kd constants).
BLI (Bio-Layer Interferometry) Kinetics:A similar method to SPR for assessing binding kinetics, often with easier operation, suitable for primary screening.

Learn more

Functional Potency & Cellular Response

This component assesses the functional biological consequences resulting from target engagement. The objective is to directly measure the drug’s efficacy in inducing a desired cellular response or inhibiting an unwanted activity. These assays demonstrate real-world drug efficacy beyond mere binding, within a relevant biological context. Key Items:

Cell-Based Functional Assays:Assays that evaluate a measurable physiological output (e.g., proliferation, migration, secretion) in response to drug treatment.
cAMP Assays:Direct measurement of the second messenger cAMP levels for drugs modulating GPCR-dependent pathways.
Luciferase Reporter Assays:Use of reporter cells to quantify the activation or inhibition of a specific signaling pathway (e.g., NFAT, STAT, Hedgehog).
Enzymatic Activity Assays:Direct assay of the catalytic activity of a target enzyme (e.g., kinase, protease) in the presence of the drug.
Pathway-Specific Functional Tests:Custom assays to evaluate specific endpoints of a pathway (e.g., protein translation, autophagy).

Learn more

In Vitro ADME & Metabolic Stability

This module predicts the fate of a drug in the body (Absorption, Distribution, Metabolism, and Excretion) at a very early stage. The aim is the early identification of potential pharmacokinetic hurdles and metabolic pathways to guide molecular structure optimization and plan in vivo studies. Key Items:

Microsomal/Hepatocyte Stability:Assessment of drug metabolism rate by liver enzymes to predict in vivo clearance.
Plasma Stability:Evaluation of drug stability in a plasma environment.
Metabolite Identification:Structural identification of primary metabolites formed.
Caco-2 / PAMPA Permeability:Prediction of oral absorption potential from the intestine.
P-gp Efflux Assay:Investigation of the drug’s potential for active efflux from specific cells (e.g., intestinal) by the P-glycoprotein pump.
Plasma Protein Binding:Measurement of the percentage of drug bound to plasma proteins (e.g., albumin), affecting free and active drug concentration.
CYP Inhibition & Induction Panels:Screening to identify a drug’s potential to inhibit or induce cytochrome P450 enzymes, which can cause drug-drug interactions.

Learn more

Advanced 3D & Complex Cellular Models

This section employs more complex models that better mimic the 3D architecture and cell-cell/matrix interactions of natural tissues. The goal is to enhance the predictive power of in vitro data by accounting for physiological complexity and tissue microenvironment. Key Items:

Tumor & Liver Organoids:3D structures derived from stem cells that mimic the function and architecture of primary tissue, for tissue-specific efficacy and toxicity studies.
3D Spheroids:Compact cellular aggregates that create oxygen/nutrient gradients and drug resistance similar to in vivo tumors.
Co-culture Systems:Simultaneous culture of two or more cell types (e.g., tumor cells and fibroblasts or immune cells) to study critical cell-cell interactions.

Learn more

Immunogenicity & Immunotoxicity Assessment

This module assesses unintended or modulatory effects of a drug on the immune system. The objective is the early identification of potential for excessive immune stimulation (e.g., cytokine storm) or undesirable immunosuppression. Key Items:

PBMC Activation Assays:Evaluation of general activation of human peripheral blood mononuclear cells in response to the drug.
Cytokine Release Assays:Measurement of the release of a broad panel of inflammatory cytokines (e.g., IL-6, TNF-α, IFN-γ) from immune cells.
T-cell Activation Markers:Measurement of activation marker expression (e.g., CD69, CD25) on T-lymphocyte subsets.
Antigen-Presenting Cell Activation:Assessment of the maturation and activation of antigen-presenting cells (e.g., dendritic cells) via surface markers (e.g., CD80, CD86, HLA-DR).

Learn more

Biophysical & Chemical Stability Profiling

This section investigates the intrinsic physicochemical properties of a drug, which have a direct and critical impact on its developability. The aim is to identify formulation, stability, and absorption-related challenges. Key Items:
- DLS (Dynamic Light Scattering):Measurement of hydrodynamic size and particle size distribution in solution to detect aggregation.
- Turbidity & Size Distribution Profiling:Monitoring turbidity and changes in particle distribution as indicators of aggregation or precipitation.
- Stress-Induced Aggregation Studies:Exposing the drug to various stresses (temperature, pH, shaking) and evaluating stability.
- Aqueous Solubility:Measurement of the equilibrium solubility of the drug in aqueous buffers at different pH levels.
- pH Stability:Evaluation of drug stability across the physiological pH range.
- LogP/LogD Determination:Measurement of the octanol/water partition coefficient (LogP at a specific pH or LogD) as an indicator of lipophilicity.
- Forced Degradation Studies:Intentional subjection of the drug to severe conditions (heat, light, oxidation, hydrolysis) to identify degradation products and instability pathways.

Learn more

info@visionofresearch.ae

14th Floor, Dubai Science Park South Tower - Al Barsha South - Dubai - UAE

+971 425 44824

Send a message.

Email Center:

Call Center:

Academic & Research Platforms

University & Discovery-Oriented Services

Mechanistic & Functional In Vitro Profiling

Send a Message

Request a Call Back

Cell Viability & Cytotoxicity Screening

Mechanistic & Molecular Pathway Assays

Target Engagement & Binding Studies

Functional Potency & Cellular Response

In Vitro ADME & Metabolic Stability

Advanced 3D & Complex Cellular Models

Immunogenicity & Immunotoxicity Assessment

Biophysical & Chemical Stability Profiling

Start Right Here – Let's Create Impact Together

Send a message.

Email Center:

Call Center:

Trusted by global brands

Need help?

Visit our Local Store

Monday-Friday: 08am-9pm

Looking for collaboration?

Keep in touch

Services